Steven W. Jones

Biography

Steven is an accomplished healthcare executive with a passion for bringing people and businesses together to form dynamic, successful partnerships. His proven ability to foster and nurture relationships has led to successful affiliations and acquisitions within the dental practice, dental laboratory and home infusion industries. Under his leadership, he and his teams have successfully closed on 50+ affiliations/acquisitions since 2008 worth more than $200M in revenue. As one of the co-founders of CORDENTAL Group™, Steven’s goal is to ensure development of a leading Dental Support Organization (DSO) that maintains a dentist-centric approach within the practices the company supports. Through his focus on practice affiliations as Chief Development Officer, he facilitates practice transitions that are uniquely designed for each situation, understanding that no two affiliations are the same and they must be designed to benefit all parties involved. Having previously been a business owner and going through the sales process himself, he has been on both sides and is empathetic to the emotions business owners experience during a transition process. The goal of CORDENTAL is to provide financial security for the practice owners, their families and staff, while providing back-office dental support that allows the practices to do what they do best… take care of their patients. Steven is a graduate of the Medical College of Virginia School of Pharmacy and holds an MBA with a concentration in healthcare management from Regis University. He previously served as the Chief Corporate Development and Integration Officer for North East Dental Management (now part of Dental Care Alliance) and as Chief Acquisition Officer for Dental Services Group, one of the largest dental laboratory groups within North America. He was Division President and Executive Vice President for Business Development for CarePoint Partners, a home infusion and specialty pharmacy company. In that capacity, he and the other executive leadership team members built the largest independent and overall fifth largest home infusion provider in the nation.  That company was successfully sold to BioScrip, a publicly-traded home infusion company, in 2013.

Research Interest

NILL.